119 related articles for article (PubMed ID: 8409984)
1. Synthesis and antitumor activity of ammine/amine platinum(II) and (IV) complexes.
Khokhar AR; Deng Y; al-Baker S; Yoshida M; Siddik ZH
J Inorg Biochem; 1993 Aug; 51(3):677-87. PubMed ID: 8409984
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and antitumor activity of amine platinum(II) and (IV) tellurate complexes.
Khokhar AR; Xu Q; Siddik ZH
J Inorg Biochem; 1994 Mar; 53(4):295-301. PubMed ID: 8169608
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and antitumor activity of a series of novel cisplatin analogs with cis-1,4-diaminocyclohexane as nonleaving amine group.
Shamsuddin S; Takahashi I; Siddik ZH; Khokhar AR
J Inorg Biochem; 1996 Mar; 61(4):291-301. PubMed ID: 8867456
[TBL] [Abstract][Full Text] [Related]
4. Ammine/amine platinum (II) complexes effective in vivo against murine tumors sensitive or resistant to cisplatin and tetraplatin.
Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
J Cancer Res Clin Oncol; 1994; 120(10):571-7. PubMed ID: 7929527
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antitumor activity, and chemical properties of silaplatin and related platinum (II) and platinum (IV) complexes derived from beta-silyl amines.
Anderson WK; Kasliwal R; Houston DM; Wang YS; Narayanan VL; Haugwitz RD; Plowman J
J Med Chem; 1995 Sep; 38(19):3789-97. PubMed ID: 7562909
[TBL] [Abstract][Full Text] [Related]
6. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375
[TBL] [Abstract][Full Text] [Related]
7. Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines.
Yoshida M; Khokhar AR; Siddik ZH
Anticancer Drug Des; 1994 Oct; 9(5):425-34. PubMed ID: 7945726
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and antitumor activity of new ethylenediamine platinum(IV) complexes containing mixed carboxylate ligands.
Khokhar AR; Deng Y; Kido Y; Siddik ZH
J Inorg Biochem; 1993 May; 50(2):79-87. PubMed ID: 8487040
[TBL] [Abstract][Full Text] [Related]
9. Chemical and biological properties of a new series of cis-diammineplatinum(II) antitumor agents containing three nitrogen donors: cis-[Pt(NH3)2(N-donor)Cl]+.
Hollis LS; Amundsen AR; Stern EW
J Med Chem; 1989 Jan; 32(1):128-36. PubMed ID: 2909724
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
Orr RM; O'Neill CF; Nicolson MC; Barnard CF; Murrer BA; Giandomenico CM; Vollano JF; Harrap KR
Br J Cancer; 1994 Sep; 70(3):415-20. PubMed ID: 8080724
[TBL] [Abstract][Full Text] [Related]
12. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and anti-tumour testing of some platinum(II) amine complexes containing 1,1- and 1,2-cyclobutanedicarboxylate ligands.
Hill WE; McAuliffe CA; Sharma HL; Zaki A
Chem Biol Interact; 1990; 73(2-3):337-51. PubMed ID: 2155716
[TBL] [Abstract][Full Text] [Related]
15. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of 1,2-diaminocyclohexane platinum(IV) complexes.
Khokhar AR; al-Baker S; Siddik ZH
J Inorg Biochem; 1994 Apr; 54(1):39-47. PubMed ID: 8151310
[TBL] [Abstract][Full Text] [Related]
17. Platinum (II) complexes of benzoic- and 3-methoxybenzoic acid hydrazides. Synthesis, characterization, and cytotoxic effect.
Dodoff N; Grancharov K; Gugova R; Spassovska N
J Inorg Biochem; 1994 May; 54(3):221-33. PubMed ID: 8027743
[TBL] [Abstract][Full Text] [Related]
18. New antitumor-active azole-bridged dinuclear platinum(II) complexes: synthesis, characterization, crystal structures, and cytotoxic studies.
Komeda S; Lutz M; Spek AL; Chikuma M; Reedijk J
Inorg Chem; 2000 Sep; 39(19):4230-6. PubMed ID: 11196916
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligand.
Yamashita T; Hirose J; Noji M; Saito R; Tomida H; Kidani Y
Biol Pharm Bull; 1993 Oct; 16(10):1014-8. PubMed ID: 8287030
[TBL] [Abstract][Full Text] [Related]
20. cis-diamineplatinum (II) complexes containing phosphono carboxylate ligands as antitumor agents.
Hollis LS; Miller AV; Amundsen AR; Schurig JE; Stern EW
J Med Chem; 1990 Jan; 33(1):105-11. PubMed ID: 2296007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
